• Users Online: 156
  • Print this page
  • Email this page
REVIEW
Year : 2019  |  Volume : 2  |  Issue : 2  |  Page : 61-67

Tumor treating fields therapy for glioblastoma: An update


Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Correspondence Address:
Dr. Eric T Wong
Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/glioma.glioma_13_19

Get Permissions

Tumor treating fields are alternating electric fields that have a therapeutic effect on newly diagnosed and recurrent glioblastomas. The fields act on cellular proteins with large dipole moment that are critical for tumor cells undergoing mitosis. This putative mechanism of mitotic disruption translates into a superior survival benefit for newly diagnosed glioblastoma patients when tested in a randomized clinical trial comparing tumor treating fields and temozolomide with temozolomide alone in the adjuvant setting. This review provides an updated summary of preclinical and clinical data, including the cell biology effects of tumor treating fields, computer simulation of the electric field distribution in patients, and the clinical efficacy data of this new therapeutic modality against glioblastoma.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed209    
    Printed16    
    Emailed0    
    PDF Downloaded50    
    Comments [Add]    

Recommend this journal